A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

NCT07075328 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult T-Cell Leukemia/Lymphoma (ATLL)

Interventions

OTHER: Drug:5-ALA, Device:Photodynamic system

Sponsor

Otsuka Medical Devices Co., Ltd. Japan

Collaborators

[object Object]